This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
investing: Archive
Is it Time to Buy the Drop in Tesla Stock Yet?
by Shaun Pruitt
Tesla (TSLA) shares have been hit mightily amid recent market volatility with the EV giant's stock down 35% year to date.
TSLANegative Net Change
auto-tires-trucks earnings electric-vehicles investing
Buy Gilead Sciences (GILD) Stock at 52-Week Highs?
by Shaun Pruitt
Medical pioneer Gilead Sciences (GILD) has seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks.
GILDNegative Net Change JNJNegative Net Change
dividends earnings investing medical pharmaceuticals
Buy Kroger or Albertsons Stock Amid Recent Market Volatility?
by Shaun Pruitt
Kroger (KR) and Albertsons (ACI) stock have hovered near 52-week highs with both acting as a defensive hedge against recent market volatility.
KRPositive Net Change ACIPositive Net Change
consumer-staples dividends earnings food investing retail
Are Tariff Concerns Overblown?
by Andrew Rocco
The Trump tariffs may have been the spark that caused the recent market pullback. However, several data points suggest that the market correction may be short-lived and that tariff concerns are overdone.
MSFTPositive Net Change NVDAPositive Net Change TSLANegative Net Change QQQNegative Net Change SPYNegative Net Change
interest-rate investing
Don't Fight the Tape: Stick with What's Working in This Market
by Bryan Hayes
Beneath the surface, a few key areas are showing strength.
AGIPositive Net Change
basic-materials earnings etfs gold inflation investing mutual-funds
Should Investors Buy Target (TGT) Stock After Favorable Q4 Results?
by Shaun Pruitt
Target (TGT) reported favorable Q4 results yesterday but has seen its stock dip 3% after the omnichannel retail giant issued cautious guidance.
TGTNo Net Change AMZNNegative Net Change WMTPositive Net Change
e-commerce earnings investing retail
3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,
by Shaun Pruitt
These highly ranked medical stocks have the value and essential services that investors may be looking for as tariff concerns and geopolitical tensions have started to rattle markets.
JAZZNegative Net Change PCRXNegative Net Change OPCHPositive Net Change
earnings genetics investing medical medical-devices pharmaceuticals
Ride the 200-day Trend With ONON, AMZN, & MSTR
by Andrew Rocco
The 200-day moving average is a handy tool that investors should use to navigate market volatility and manage risk. Investors can identify potential buy opportunities during market dips by focusing on this powerful long-term trend indicator.
AMZNNegative Net Change QQQNegative Net Change MSTRNegative Net Change HOODNegative Net Change ONONNegative Net Change
artificial-intelligence cloud-computing e-commerce investing
Buy Johnson & Johnson (JNJ) Stock for Higher Highs?
by Shaun Pruitt
Amid recent market volatility, Johnson & Johnson (JNJ) stock hit new 52-week highs of nearly $170 on Tuesday.
JNJNegative Net Change PFENegative Net Change LLYNegative Net Change ABBVNegative Net Change
earnings investing large-cap medical medical-devices pharmaceuticals vaccines
Pharmaceutical Stocks Hit New Highs Amid Market Volatility
by Bryan Hayes
During this time of heightened market volatility, it pays to be invested in the right places.
GILDNegative Net Change
cancer cell-therapy coronavirus earnings immuno-therapy investing medical oncology-screening vaccines